Researchers have uncovered a stealth survival strategy that melanoma cells use to evade targeted therapy, offering a ...

After announcing major reforms, prime minister Keir Starmer has pledged that his office will play a key role in helping ...

Researchers have uncovered a promising therapeutic target for adenoid cystic carcinoma (ACC), a rare cancer of the salivary ...

Scientists uncovered a key genetic pathway in the origin of feathers, but they found that evolution is stubborn in turning ...

Fully enrolled LORIKEET, a randomized 150-patient Phase 2 study of lorigerlimab in combination with docetaxel in patients ...

We will begin the MacroGenics fourth quarter and full year 2024 corporate progress and financial results conference call in just a moment. All participants are in a listen-only mode, and we will ...

TiumBio (KOSDAQ: 321550), a clinical-stage biopharmaceutical company focused on discovering and developing innovative ...

Reports Q4 revenue $60.6M, consensus $51.9M. “We continue to make excellent progress with our clinical and preclinical molecular glue degrader ...

Cassava Sciences explores simufilam's potential for seizures in tuberous sclerosis. Results for Alzheimer's trials expected ...

They found that PPD can contribute to children's emotional overeating through psychological and cognitive pathways. The ...

Current guidelines lack consensus and rely on lower-quality evidence, according to the author of new research.

Advancement of oral, brain-penetrant NLRP3 inhibitor BGE-102, with initial clinical data expected 2H25Progression of preclinical next-generation ...